Market Value1,667,158,944
Total Holdings63
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SYK / Stryker Corporation
SANA / Sana Biotechnology, Inc.
IRTC / iRhythm Holdings, Inc.
HOWL / Werewolf Therapeutics, Inc.
UHS / Universal Health Services, Inc.
BSX / Boston Scientific Corporation
VRTX / Vertex Pharmaceuticals Incorporated
ZBH / Zimmer Biomet Holdings, Inc.
UNH / UnitedHealth Group Incorporated
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
IOBT / IO Biotech, Inc.
EPIX / ESSA Pharma Inc.
BLUE / bluebird bio, Inc.
BDX / Becton, Dickinson and Company
US516544AB96 / CONV. NOTE
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
KRTX / Karuna Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
HCA / HCA Healthcare, Inc.
MRK / Merck & Co., Inc.
TMO / Thermo Fisher Scientific Inc.
PRTA / Prothena Corporation plc
MOH / Molina Healthcare, Inc.
PEN / Penumbra, Inc.
IQV / IQVIA Holdings Inc.
GBIO / Generation Bio Co.
IMGN / ImmunoGen, Inc.
EDIT / Editas Medicine, Inc.
RCUS / Arcus Biosciences, Inc.
SGEN / Seagen Inc
PNT / POINT Biopharma Global Inc.
VRDN / Viridian Therapeutics, Inc.
NARI / Inari Medical, Inc. Put
LNTH / Lantheus Holdings, Inc.
BMRN / BioMarin Pharmaceutical Inc. Call
ALKS / Alkermes plc
MCK / McKesson Corporation
HUM / Humana Inc.
CYTK / Cytokinetics, Incorporated
IMVT / Immunovant, Inc.
ICLR / ICON Public Limited Company
AXSM / Axsome Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
EYPT / EyePoint, Inc.
BMRN / BioMarin Pharmaceutical Inc.
LLY / Eli Lilly and Company
DXCM / DexCom, Inc.
THC / Tenet Healthcare Corporation
ROIV / Roivant Sciences Ltd.
CAH / Cardinal Health, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
CNC / Centene Corporation
ACHC / Acadia Healthcare Company, Inc.
EW / Edwards Lifesciences Corporation
PRAX / Praxis Precision Medicines, Inc.
BIIB / Biogen Inc.
CELC / Celcuity Inc.
ABBV / AbbVie Inc.
DHR / Danaher Corporation
CLDX / Celldex Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
US64157FAC77 / Nevro Corp
INBX / Inhibrx Biosciences, Inc.
US23282WAC47 / CONV. NOTE
ACLX / Arcellx, Inc.
SGMT / Sagimet Biosciences Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AKRO / Akero Therapeutics, Inc.
ELV / Elevance Health, Inc.
TSBX / Turnstone Biologics Corp.
SRPT / Sarepta Therapeutics, Inc.
OSCR / Oscar Health, Inc.
CRBU / Caribou Biosciences, Inc.
VEEV / Veeva Systems Inc.
OM / Outset Medical, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
AVTR / Avantor, Inc.
ERAS / Erasca, Inc.
PMVP / PMV Pharmaceuticals, Inc.